Introducing our Early Stage Strategy service
|20th February 2020
Blue Latitude Health introduces our new Early Stage Strategy service, designed to align commercial and medical teams and emphasise the value of the product for the patient, healthcare professional and business from the early phases of drug development.
To learn more about the service - click on the one-pager below and contact mark.assenti@bluelatitude.com
Our content has moved
|18th November 2020
We’re posting all new articles on our parent website fishawack.com
Fishawack Health launches Delta Magazine
|17th November 2020
Our parent company Fishawack Health has launched a new magazine with a first issue unpacking rare disease.
In the precision medicine era, the line between products and services is blurred
|27th August 2020
Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?